Related Experiment Video
Updated: Sep 23, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Low levels of vitamin D and coronary artery disease: Is it time for therapy?
Monica Verdoia1,2, Rocco Gioscia1, Matteo Nardin3
1Division of Cardiology, Ospedale degli Infermi, ASL Biella, Biella, Italy.
Insights
Vitamin D deficiency is common and linked to coronary artery disease (CAD). This review examines vitamin D
Area of Science:
- Cardiology
- Endocrinology
- Nutritional Science
Background:
- Growing prevalence of vitamin D deficiency (hypovitaminosis D) globally.
- Established links between vitamin D levels and coronary artery disease (CAD) risk and severity.
- Inconsistent findings regarding vitamin D supplementation efficacy in primary cardiovascular prevention.
Purpose of the Study:
- To provide an updated review of evidence on vitamin D and CAD.
- To explore potential therapeutic applications of vitamin D in patients with established CAD.
- To address the importance of vitamin D in cardiovascular health.
Main Methods:
- Comprehensive literature review of observational studies and meta-analyses.
- Analysis of data on vitamin D association with CAD prevalence, severity, and ischemic events.
- Evaluation of existing research on vitamin D supplementation in primary prevention and established CAD.
Main Results:
- Consistent associations demonstrated between vitamin D status and CAD prevalence/severity.
- Prognostic implications of vitamin D levels in cardiovascular health are significant.
- Vitamin D supplementation trials show mixed results, particularly in primary prevention.
Conclusions:
- Further research is needed to clarify the role of vitamin D in established CAD.
- Optimization of vitamin D therapeutic strategies is crucial for cardiovascular health.
- The review highlights the need for evidence-based guidelines for vitamin D use in CAD patients.
Abstract:
The association between vitamin D and the prevalence and severity of coronary artery disease (CAD), major established cardiovascular risk factors, and acute ischemic events has been consistently demonstrated in large-scale observational studies and meta-analyses, with relevant prognostic implications. The rise in prevalence of hypovitaminosis D in recent years, reaching pandemic pro-portions, has pointed to the importance of the identification and optimization of the indications and strategies for the therapeutic use of vitamin D, with particular relevance for cardiovascular health. However, vitamin D supplementation has provided so far inconsistent results in primary prevention, with even fewer data reported in patients with established CAD. The present review aims to provide an updated overview of the available evidence and potential therapeutic applications of vitaminD in patients with CAD.
More Related Videos
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management

